Editor´s Pick

      Editor´s Pick

      Merck and Ridgeback Announce Supply Agreement with UNICEF for Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine

      KENILWORTH, N.J. & MIAMI--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced the signing of...
      Admin -
      Editor´s Pick

      Study Highlights Connections Between Addictive Drugs and Brain Function

      LEMONT, Ill.--(BUSINESS WIRE)--A 1980s commercial to combat drug addiction used a pair of frying eggs as a metaphor for the effects of drugs on...
      Admin -
      Editor´s Pick

      Editor´s Pick | Research Professional  News; Pharma industry draws up guidelines for sharing data

      Europe’s pharmaceutical industry trade body has developed a code of conduct on data protection in clinical research, which will soon be submitted to EU...
      Admin -
      Editor´s Pick

      EDITOR´S PICK; REUTERS; EU drug regulator expresses doubt on need for fourth booster dose

      Jan 11 (Reuters) - The European Union's drug regulator on Tuesday expressed doubts about the need for a fourth booster dose of COVID-19 vaccine...
      Admin -
      Editor´s Pick

      EDITOR´S PICK; REUTERS; WHO body says COVID-19 vaccines may need to be updated for Omicron

      GENEVA, Jan 11 (Reuters) - A World Health Organization technical body said on Tuesday that current COVID-19 vaccines may need to be reworked to...
      Admin -
      Editor´s Pick

      EDITOR´S PICK Tie pharma CEO pay to fair global COVID-19 vaccine access, investors say

      AMSTERDAM, Jan 6 (Reuters) - A group of institutional investors representing $3.5 trillion in assets under management on Thursday called on pharmaceutical companies to...
      Admin -
      1234Page 1 of 4

      Recent Articles

      Revance Receives Clarity on Path to Resubmission of the BLA for DaxibotulinumtoxinA for Injection Following Type A Meeting with FDA

      Regulatory Affairs

      McKesson’s Board of Directors Elects James H. Hinton and Kathleen Wilson-Thompson as New Directors

      Look Who’s On the Move!

      Professor Charlotte Deane Joins Exscientia as Chief Scientist of Biologics AI

      Look Who’s On the Move!

      Gamida Cell Provides Update on Omidubicel BLA Submission

      Regulatory Affairs

      VFMCRP receives EU approval for Tavneos® for the treatment of ANCA-associated vasculitis

      Regulatory Affairs

      Expansion Therapeutics Appoints Gary Bridger, Ph.D., to Its Board of Directors

      Look Who’s On the Move!

      Merck and Ridgeback Announce Supply Agreement with UNICEF for Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine

      Editor´s Pick

      bluebird Provides Update on FDA Review Timelines for Betibeglogene Autotemcel (beti-cel) for Beta-Thalassemia and Elivaldogene Autotemcel (eli-cel) for Cerebral Adrenoleukodystrophy (CALD)

      Regulatory Affairs

      CorVista Health Appoints Charles R. Bridges as Chief Scientific Officer

      Look Who’s On the Move!

      OnKure Therapeutics Appoints Nicholas A. Saccomano, Ph.D., to its Board of Directors

      Look Who’s On the Move!

      Exo Therapeutics Appoints Antonio Gualberto as President of Research & Development and Chief Medical Officer

      Look Who’s On the Move!

      Ami Bavishi Joins Rallybio to Lead Investor Relations and Corporate Communications

      Look Who’s On the Move!

      TandemAI Announces Expansion of Senior Leadership Team

      Look Who’s On the Move!

      Vasomune and AnGes Announce First Patient Enrolled in Phase 2a Clinical Study Evaluating AV-001 for the Treatment of Severe COVID-19 Disease

      Industry News

      Aptorum Group Granted The First Patent for its SACT-1 Repurposed Drug For Treatment of Various Cancer Including but Not Limited to Neuroblastoma

      Industry News

      2021 © Copyright - TPMG

      Get a free copy of "Cracking the Generics Code"

      Looks like you are using an ad-blocking browser extension. We request you to whitelist our website on the ad-blocking extension and refresh your browser to view the content.